Articles tagged with Flu Vaccines
A new Cleveland Clinic study of over 13,000 patients found no link between influenza vaccination and COVID-19 risk. The researchers strongly advise people to get their flu vaccines this fall to mitigate the risk of simultaneous viral infections and epidemics.
A new study found that 69% of Americans would definitely or probably get a COVID-19 vaccine when available. However, only 55% of Black Americans showed similar interest due to potential barriers such as access to care and trust in healthcare.
Researchers at WashU Medicine developed an approach to assess vaccine activation in lymph nodes, showing that the flu vaccine can elicit antibodies protecting against a broad range of flu viruses. The findings could aid in designing an improved flu vaccine providing protection against old and new strains.
A large cohort study found no association between maternal H1N1 vaccination during pregnancy and risk for autism spectrum disorder (ASD) in children. Researchers also found that vaccine exposure in the first trimester did not increase ASD or autistic disorder (AD) risks.
A study of nearly 3 million Americans found that influenza and pneumonia vaccinations significantly reduced hospital death rates among patients with heart failure. Vaccination coverage remains low, but the study's findings support annual immunizations for patients with heart failure to prevent respiratory infections.
A CDC study of over 80,000 adult patients hospitalized with flu found that sudden, serious heart complications occurred in 12% of patients, or 1 in 8. The study underscores the importance of getting a flu shot early to prevent these complications. Researchers recommend that everyone 6 months and older get a flu vaccine every flu season.
A new study found that US adults' flu vaccination rates differ significantly by demographics such as age, insurance status, and chronic conditions. The researchers suggest that boosting vaccination rates requires a concerted public health campaign and proactive primary care outreach strategy.
A city-wide school influenza vaccine intervention was associated with a decrease in influenza-associated hospitalizations and school absences. The study found that SLIV programs increased vaccination coverage and reduced influenza across communities.
Researchers found that seasonal flu vaccination boosts antibody-producing cells, but most are lost within a year. The study suggests longer-lasting 'universal' flu vaccines and improved vaccine design could address this issue.
Research found that dialysis facilities with larger proportions of Black and Hispanic patients had significantly lower flu vaccination percentages than less diverse facilities. The study highlights the need for targeted vaccination outreach programs to protect vulnerable communities.
A new study using big data and survey results from the 2018-19 flu season found strong associations between regional social media messages and vaccination attitudes and behavior. However, when people discussed vaccination with others, negative effects of social media on vaccine behavior disappeared.
A study finds that immune suppression in older adults is reversible and can be relieved by targeting a specific cell type. This breakthrough could lead to more effective flu vaccines and potentially COVID-19 vaccines, increasing protection for seniors.
Research reveals flu vaccinations can reduce Alzheimer's incidence by up to 17%, with pneumococcal vaccination showing a similar protective effect. Vaccination also found to reduce mortality in people with dementia.
Research finds flu vaccination significantly lowers risk of heart attack, TIA, death, and cardiac arrest in adults over 50 and high-risk groups. Vaccination rates are under-utilized, especially among vulnerable populations, emphasizing the importance of increasing flu vaccinations.
A study by Emory Vaccine Center found that adjuvants can strengthen both rookie and veteran elements of the immune response to a vaccine containing H5N1. This has significant implications for developing universal flu vaccines against multiple strains, as well as optimizing responses against SARS-CoV-2.
Researchers identified an enhanced immune response to the H5N1 influenza virus in a two-dose vaccination trial. The findings suggest that this approach could lead to the development of a universal flu vaccine targeting multiple strains.
A new study published in eLife found that early exposure to the flu virus can reduce the risk of future infections, particularly with the same subtype. The study also showed that the effectiveness of flu vaccines varies with age and birth year, suggesting that early exposure plays a role in shaping immune responses.
Researchers found that one flu strain, H3N2, can mutate relatively easily to escape broad-acting antibodies, while another strain, H1N1, is more difficult to evade. The study highlights the challenges involved in designing a universal flu vaccine and suggests that further research is needed to develop an effective treatment.
A national study found 6.1% of parents hesitant about routine childhood immunizations while nearly 26% were hesitant about the influenza vaccine. The researchers suggest focusing on changing behavior rather than directly countering beliefs or attitudes to combat hesitancy.
Researchers found a strong association between flu vaccine coverage and reduced antibiotic use in the US. The study suggests that expanding flu vaccine coverage could reduce inappropriate antibiotic prescribing and mitigate the growing problem of antibiotic resistance.
A new study suggests that using mice with pre-existing illnesses could improve the accuracy of flu vaccine development and efficacy. The researchers found that dirty mice showed more extensive lung damage from influenza A virus than clean mice, indicating a potentially less effective vaccine in these animals.
Researchers have successfully developed a MERS vaccine that fully protects mice against the deadly virus, and it may hold promise for developing vaccines against COVID-19. The vaccine uses a harmless virus to deliver a MERS coronavirus protein into cells, generating an immune response.
Between 2008-2018, deaths from infectious diseases decreased steadily, with a significant shift towards HIV/AIDS among 15-24 year olds. Traditional vaccine-preventable diseases have largely disappeared, but seasonal and unpredictable diseases remain a concern.
A large cohort study published in Annals of Internal Medicine found that apixaban was associated with a lower risk of stroke or systemic blood clots compared to rivaroxaban in patients with nonvalvular atrial fibrillation. The study also showed that apixaban was linked to a lower risk of gastrointestinal bleeding or bleeding in the brain.
Adding travel history to patient evaluation could help identify risk for potential exposure to COVID-19. The authors argue that this simple measure can trigger more detailed history, appropriate testing, and rapid implementation of protective measures.
A recent study found that social media significantly increased expressions of distrust in government regarding vaccines after the 2018 Changchun Changsheng Biotechnology vaccine incident. The researchers also observed a decrease in self-reports of vaccination and expressed support for vaccine acceptance in China.
A Rutgers-led team has created a tool to monitor live influenza A virus mutations in real time, allowing for the analysis of viral RNA without killing cells. This breakthrough could aid virologists in understanding and stopping viral replication.
Experts cite urgent need for influenza vaccinations to prevent outbreaks in detained migrants and asylum seekers. The logistics of vaccine administration are relatively straightforward, with a low risk of adverse effects.
A recent study published in Clinical Infectious Disease found that full influenza vaccination among children reduces the risk of hospitalization associated with influenza by 54%. The study, conducted in Israel, tested the effectiveness of childhood vaccination against influenza and risk of hospitalization due to complications.
A new study published in Clinical Infectious Disease found that fully vaccinating children reduced the risk of hospitalization for influenza complications by 54%. The research, led by Dr. Hannah Segaloff and Prof. Mark Katz, validated guidelines recommending two vaccine doses for children under 8 who have never been vaccinated or recei...
A new Penn Medicine study developed an mRNA vaccine that successfully protected young mice against influenza and other pathogens in the presence of maternal antibodies. The vaccine worked by continuously producing antigens, eliciting a prolonged immune response.
Researchers developed a novel nanoparticle vaccine that combines M2e and NA proteins, providing strong cross-protection against six different influenza virus strains. The vaccine offers potential as a universal flu vaccine or component of such vaccines.
Researchers found that injecting influenza vaccines into tumors increases the immune system's response, changing cold tumors to hot ones. This triggers an immune-stimulating effect, reducing tumor growth and improving survival rates. The study suggests that flu shots could be repurposed as cancer treatments.
Researchers found that injecting seasonal flu vaccines into tumors in mice increased systemic immune responses and sensitivity to treatments. The results suggest that antipathogen vaccines may find additional benefit as cancer immunotherapies, potentially converting cold tumors to 'hot' states.
Researchers from the University of Konstanz conducted an experimental study on how vaccination arguments propagate in online chains. The study found that existing vaccination beliefs are resilient to radicalization and do not become more extreme even when exposed to opposing views. This has significant implications for public health, h...
A team of Brown University researchers will compare two licensed flu vaccines in up to 1,000 nursing homes to identify the most effective one for elderly residents. The study aims to inform public health decision-making and improve healthcare outcomes for this vulnerable population.
A new study found that only 24.5% of child care center directors reported having a flu vaccine requirement for children, and even fewer for adult caregivers. However, states with laws mandating flu vaccination for children in day care were more likely to have requirements.
A new study suggests that immersive virtual reality can increase the acceptance of flu vaccinations among adults aged 18-49. The research found that participants who experienced a five-minute virtual reality simulation showed increased concern about transmitting flu to others and were more confident in the effectiveness of vaccination.
Researchers at Michigan State University have found that cellular RNA levels change significantly following infection or vaccination. The study's findings could help identify new targets for building better flu vaccines and aid in the design of a universal vaccine.
Researchers at Colorado State University aim to create a new and improved TB vaccine, which has shown strong immune response in early-stage clinical trials. The project will include a multidisciplinary team of over 20 researchers and scientists to better understand the immune responses required for protection against TB.
Researchers at Scripps Research have found an antibody that protects against a wide range of influenza viruses by targeting the neuraminidase protein. The discovery could lead to the development of a universal flu vaccine that offers broad protection against human, swine, and avian strains.
Researchers have isolated three broadly protective human antibodies targeting the influenza virus neuraminidase protein, providing strong protection against various strains in vitro and mice. These antibodies could inform the development of new antiviral treatments and HA-based vaccines with longer-lasting immunity.
A newly discovered antibody protects mice against a wide range of lethal influenza viruses, representing human, swine, and avian strains. The antibody could serve as a template to design a universal flu vaccine and treat severe cases of flu.
A clinical trial is recruiting volunteers aged 18-50 to be deliberately infected with influenza virus under controlled conditions. The study aims to assess the impact of pre-existing antibodies on flu symptoms, fever and muscle aches. Volunteers will undergo follow-up clinic visits for up to 90 days after challenge.
Dr. Kathleen Neuzil's pivotal research informed global vaccine policy, saving millions worldwide. As a member of the National Academy of Medicine, she will continue to shape public health policy.
Researchers at Mount Sinai develop a novel vaccine using chimeric hemagglutinin, inducing broad antibody responses against human and avian influenza viruses. The study shows promise for a universal flu vaccine, but interim results indicate further work is needed.
Researchers discovered a 'senescence' pattern in influenza virus surface protein mutations, making it harder to predict future changes. This understanding can improve vaccine strain selection, ultimately enhancing protection against seasonal flu outbreaks.
The NIH has initiated a collaborative influenza vaccine research network to develop more durable and broadly protective vaccines. The CIVICs program will support the development of universal influenza vaccines with longer-lasting protection against a wider variety of influenza viruses.
Replacing seasonal vaccines with universal ones could avert over 17 million cases and 251,000 hospitalizations per year. States with high hospitalization costs and elderly populations would experience the greatest economic benefits.
The University of Maryland School of Medicine has been awarded a $200 million contract from the National Institute of Allergy and Infectious Diseases to develop and test new influenza vaccines. The research aims to protect against emerging flu strains and improve seasonal vaccines.
A new needle-free flu vaccine patch has been developed that effectively stimulates the immune system without negative side effects. The patch uses a synthetic peptide to disrupt the skin barrier, allowing the flu vaccine virus to be delivered, and has shown promise in early human trials.
Researchers at OHSU are developing a new flu vaccine using the CMV-based platform, which has shown promise in fighting tuberculosis and an HIV-like virus. The goal is to create a longer-lasting, universally effective vaccine that could replace annual shots.
Researchers found that oral antibiotics can alter human immune responses to seasonal influenza vaccination, potentially hindering protection against infection. Antibiotics also promoted pro-inflammatory states in the body, similar to conditions seen in older adults who have received influenza vaccines.
Researchers found that flu vaccination is associated with a 18% reduced risk of death from all causes, a 16% reduced risk of cardiovascular deaths, and a 10% reduced risk of heart attacks or strokes in patients with high blood pressure.
Researchers at Cornell University have discovered that combining proteins from two lethal viruses can enhance their pathogenic potential. The team found that a hybrid protein pair has greater fusion capability, which could be leveraged to stop viral-cell fusion and develop more effective vaccines.
A Phase 1 clinical trial enrolls healthy adults to evaluate the safety and immune response of two licensed influenza vaccines administered with novel adjuvants. The trial aims to improve seasonal flu vaccine effectiveness, which varies from year to year.
Elderly intensive care patients who have been vaccinated against influenza have a reduced risk of dying and suffering a blood clot or bleeding in the brain. The study found an eight percent lower risk of dying during the first year following hospitalization for those who were vaccinated.
A simple pamphlet about the flu given to parents in pediatrician's waiting room increased vaccination rates among young children. The study, published in Pediatrics, found nearly 72% of vaccinated children received the handout compared to around 65% without.
A Canadian study of over 100,000 children born to vaccinated mothers during the 2009 H1N1 pandemic found no association with increased risk of health problems. However, some slight associations were observed for gastrointestinal infections and asthma, but these were small and may be due to confounding factors.
Dr. Baozhong Wang is developing a multivalent layered nanocluster vaccine that can act against multiple influenza virus strains, using conserved antigenic proteins from both A and B viruses. The goal is to induce broadly reactive immune responses providing cross-protection against both influenza A and B viruses.